Takeda Pharmaceutical
TAK
S$19.14
Share price
-1.19%
Change (1 day)
7.57%
Change (1 year)
Categories
Earnings for Takeda Pharmaceutical (TAK)
Earnings in 2024 (TTM): S$2.94 Billion
According to Takeda Pharmaceutical's latest financial reports the company's current earnings are S$29.97 Billion. a decrease over its 2023 earnings that were of S$2.93 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Takeda Pharmaceutical from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | S$2.87 B | -1.9% |
| 2023 | S$2.93 B | -28.11% |
| 2022 | S$4.08 B | -41.15% |
| 2021 | S$6.93 B | 78.15% |
| 2020 | S$3.89 B | 246.83% |
| 2019 | S$1.12 B | -48.74% |
| 2018 | S$2.19 B | -23.86% |
| 2017 | S$2.87 B | 21.77% |
| 2016 | S$2.36 B | -253.22% |
| 2015 | -S$1.55 Billion | -159.7% |
| 2014 | S$2.58 B | 12.76% |
| 2013 | S$2.29 B | 2.7% |
| 2012 | S$2.23 B | -57.11% |
| 2011 | S$5.19 B | -10.11% |
| 2010 | S$5.78 B | -4.2% |
| 2009 | S$6.03 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | S$35.22 B | 1,123.54% | 🇺🇸 USA |
 Sanofi SNY | S$11.28 B | 291.97% | 🇫🇷 France |
 Pfizer PFE | S$13.29 B | 361.64% | 🇺🇸 USA |
 Novartis NVS | S$19.17 B | 565.97% | 🇨🇭 Switzerland |
 Seagen
SGEN | -S$1.02 Billion | -135.29% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | S$1.13 B | -60.71% | 🇮🇳 India |
 Amgen AMGN | S$8.54 B | 196.87% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$6.95 B | 141.56% | 🇬🇧 UK |
 Merck MRK | S$27.56 B | 857.57% | 🇺🇸 USA |